Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clonal and Scalable Endothelial Progenitor Cell Lines from Human Pluripotent Stem Cells. | Biomedicines | 2023 | 37893151 | PubTator, text mining | PubMed |
| Deubiquitylating Enzymes in Cancer and Immunity. | Adv Sci (Weinh) | 2023 | 37888853 | PubTator, text mining | PubMed |
| USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. | PLoS One | 2023 | 37874827 | PubTator, text mining | PubMed |
| Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods. | Iran Biomed J | 2023 | 37873683 | PubTator, text mining | PubMed |
| Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. | Adv Sci (Weinh) | 2023 | 37867237 | PubTator, text mining | PubMed |
| Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems. | Clin Epigenetics | 2023 | 37858233 | PubTator, text mining | PubMed |
| IGF-1R targeting in cancer - does sub-cellular localization matter? | J Exp Clin Cancer Res | 2023 | 37858153 | PubTator, text mining | PubMed |
| Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. | Science | 2023 | 37856615 | PubTator, text mining | PubMed |
| Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma. | BMC Med Genomics | 2023 | 37853449 | PubTator, text mining | PubMed |
| Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics. | Circulation | 2023 | 37850387 | PubTator, text mining | PubMed |
| The admixed brushtail possum genome reveals invasion history in New Zealand and novel imprinted genes. | Nat Commun | 2023 | 37848431 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment. | Cancers (Basel) | 2023 | 37835519 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA. | Cells | 2023 | 37830614 | PubTator, text mining | PubMed |
| Conjugation with glucagon like peptide-1 enables targeted protein degradation. | Bioorg Chem | 2023 | 37827016 | PubTator, text mining | PubMed |
| Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release. | EMBO Rep | 2023 | 37818801 | PubTator, text mining | PubMed |
| Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions. | Front Oncol | 2023 | 37817767 | PubTator, text mining | PubMed |
| Cell-specific secretory granule sorting mechanisms: the role of MAGEL2 and retromer in hypothalamic regulated secretion. | Front Cell Dev Biol | 2023 | 37799273 | PubTator, text mining | PubMed |
| The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. | Front Endocrinol (Lausanne) | 2023 | 37795365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=13